company background image
AVE logo

Avecho Biotechnology ASX:AVE Stock Report

Last Price

AU$0.003

Market Cap

AU$9.5m

7D

0%

1Y

-50.0%

Updated

16 Jun, 2024

Data

Company Financials

Avecho Biotechnology Limited

ASX:AVE Stock Report

Market Cap: AU$9.5m

AVE Stock Overview

A biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia.

AVE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Avecho Biotechnology Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Avecho Biotechnology
Historical stock prices
Current Share PriceAU$0.003
52 Week HighAU$0.009
52 Week LowAU$0.003
Beta1.98
1 Month Change0%
3 Month Change0%
1 Year Change-50.00%
3 Year Change-83.33%
5 Year Change-25.00%
Change since IPO-99.38%

Recent News & Updates

Recent updates

Companies Like Avecho Biotechnology (ASX:AVE) Are In A Position To Invest In Growth

Jan 13
Companies Like Avecho Biotechnology (ASX:AVE) Are In A Position To Invest In Growth

Here's Why We're Watching Avecho Biotechnology's (ASX:AVE) Cash Burn Situation

May 31
Here's Why We're Watching Avecho Biotechnology's (ASX:AVE) Cash Burn Situation

Avecho Biotechnology (ASX:AVE) Is In A Good Position To Deliver On Growth Plans

Nov 04
Avecho Biotechnology (ASX:AVE) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Avecho Biotechnology (ASX:AVE) Will Use Its Cash Wisely

Jul 14
We're Hopeful That Avecho Biotechnology (ASX:AVE) Will Use Its Cash Wisely

We Think Avecho Biotechnology (ASX:AVE) Can Afford To Drive Business Growth

Mar 23
We Think Avecho Biotechnology (ASX:AVE) Can Afford To Drive Business Growth

We're Not Very Worried About Avecho Biotechnology's (ASX:AVE) Cash Burn Rate

Dec 08
We're Not Very Worried About Avecho Biotechnology's (ASX:AVE) Cash Burn Rate

Shareholder Returns

AVEAU PharmaceuticalsAU Market
7D0%1.5%-1.7%
1Y-50.0%62.7%7.0%

Return vs Industry: AVE underperformed the Australian Pharmaceuticals industry which returned 62.7% over the past year.

Return vs Market: AVE underperformed the Australian Market which returned 7% over the past year.

Price Volatility

Is AVE's price volatile compared to industry and market?
AVE volatility
AVE Average Weekly Movement43.8%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement8.7%
10% most volatile stocks in AU Market16.3%
10% least volatile stocks in AU Market3.2%

Stable Share Price: AVE's share price has been volatile over the past 3 months.

Volatility Over Time: AVE's weekly volatility has increased from 35% to 44% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992n/aPaul Gavinavecho.com.au

Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations.

Avecho Biotechnology Limited Fundamentals Summary

How do Avecho Biotechnology's earnings and revenue compare to its market cap?
AVE fundamental statistics
Market capAU$9.51m
Earnings (TTM)-AU$3.44m
Revenue (TTM)AU$473.55k

20.1x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AVE income statement (TTM)
RevenueAU$473.55k
Cost of RevenueAU$517.35k
Gross Profit-AU$43.79k
Other ExpensesAU$3.39m
Earnings-AU$3.44m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0011
Gross Margin-9.25%
Net Profit Margin-725.70%
Debt/Equity Ratio0%

How did AVE perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.